CJ CheilJedang Corp
KRX:097950
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
240 500
398 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
CJ CheilJedang Corp
CJ CheilJedang Corp
Additional Paid In Capital
CJ CheilJedang Corp
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CJ CheilJedang Corp
KRX:097950
|
Additional Paid In Capital
₩1.5T
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
|
|
Ottogi Corp
KRX:007310
|
Additional Paid In Capital
₩322.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
20%
|
CAGR 10-Years
45%
|
|
|
S
|
Samyang Foods Co Ltd
KRX:003230
|
Additional Paid In Capital
₩10.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dongwon Industries Co Ltd
KRX:006040
|
Additional Paid In Capital
₩1.6T
|
CAGR 3-Years
147%
|
CAGR 5-Years
72%
|
CAGR 10-Years
42%
|
|
|
Orion Corp
KRX:271560
|
Additional Paid In Capital
₩598.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Nongshim Co Ltd
KRX:004370
|
Additional Paid In Capital
₩121.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
CJ CheilJedang Corp
Glance View
CJ CheilJedang Corp., originally founded in 1953 as a sugar manufacturer in South Korea, has evolved into a global powerhouse in the food and bio sectors. The company’s journey began with its efforts to meet post-war food shortages, quickly establishing itself as a staple in Korea's culinary life through its sugar, flour, and cooking oil products. Over the decades, CJ CheilJedang has innovated and diversified its portfolio, becoming a leader in food products both domestically and internationally. This transformation was marked by their expansion into processed foods, instant meals, and health-oriented products, appealing to a wide range of consumer needs. This broad array of offerings is powered by a deep investment in R&D and a keen eye on global food trends, underscoring their agility in pivoting to the demands of a growing global market. Their emphasis on quality and innovation has cultivated a brand synonymous with trust and reliability, extending their reach far beyond the Korean Peninsula. Beyond food, CJ CheilJedang has carved a significant niche in the bioengineering and pharmaceutical sectors. The company's foray into biotechnology positions it strategically at the intersection of science and agriculture, where they produce amino acids and other bio-products that are essential in animal feed and various industrial applications. This diversification is not just an expansion but a strategic alignment with global sustainability trends and the rising demand for bioproducts that are environmentally friendly. By spanning across food production and biotechnology, CJ CheilJedang minimizes risk and enhances its revenue streams, ensuring a resilient business structure. Their integrated approach combines state-of-the-art technology with environmental stewardship, driving its business forward in an increasingly eco-conscious world. Through strategic acquisitions and partnerships, they have fortified their position both vertically and horizontally within the markets they serve, thereby shaping a robust framework for sustained growth.
See Also
What is CJ CheilJedang Corp's Additional Paid In Capital?
Additional Paid In Capital
1.5T
KRW
Based on the financial report for Sep 30, 2024, CJ CheilJedang Corp's Additional Paid In Capital amounts to 1.5T KRW.
What is CJ CheilJedang Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
6%
Over the last year, the Additional Paid In Capital growth was 0%.
You don't have any saved screeners yet